RT

RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş.

Develops and produces IVD kits and biological pharmaceuticals for the healthcare sector.

RTALB | IS

Overview

Corporate Details

ISIN(s):
TRERTAL00018
LEI:
Country:
Türkiye
Address:
N/A
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

RTA Laboratuvarları, established in 1996, is a biotechnology company specializing in the research, development, and production of in-vitro diagnostic (IVD) products and biological pharmaceuticals. The company focuses on the fields of molecular biology and microbiology, utilizing its advanced R&D laboratories and expert personnel to develop a wide range of diagnostic kits and related biological materials. Its core activities include the production and distribution of domestic diagnostic solutions for the healthcare sector, with specific product lines in molecular biology, microbiology, and COVID-19 diagnostics. The company is committed to innovation and development in the molecular biotechnology field.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-27 16:10
Annual / Quarterly Financial Statement
Sorumluluk Beyanı (30.09.2025)
Turkish 21.9 KB
2025-10-27 16:10
Quarterly Report
Faaliyet Raporu (30.09.2025)
Turkish 848.8 KB
2025-10-27 16:10
Report Publication Announcement
Faaliyet Raporu (30.09.2025)
Turkish 11.2 KB
2025-10-27 16:10
Quarterly Report
Financial Report
Turkish 1.9 MB
2025-10-27 16:10
Annual / Quarterly Financial Statement
Financial Report
English 2.5 MB
2025-08-11 17:10
Environmental & Social Information
Participation Finance Principles Information Form
English 52.9 KB
2025-08-08 18:55
Annual / Quarterly Financial Statement
Sorumluluk Beyanı (30.06.2025)
Turkish 21.9 KB
2025-08-08 18:55
Interim Report
Faaliyet Raporu (30.06.2025)
Turkish 902.6 KB
2025-08-08 18:55
Report Publication Announcement
Faaliyet Raporu (30.06.2025)
Turkish 11.2 KB
2025-08-08 18:55
Interim Report
Financial Report
Turkish 1.9 MB
2025-08-08 18:55
Annual / Quarterly Financial Statement
Financial Report
English 2.5 MB
2025-07-07 11:10
Post-Annual General Meeting Information
2025 Yılı Bağımsız Denetim Şirketi Seçiminin Tescili ve İlanı
Turkish 29.4 KB
2025-07-07 11:08
Post-Annual General Meeting Information
2. Olağan Genel Kurulu Tescil ve İlanı
Turkish 414.9 KB
2025-07-07 11:08
Post-Annual General Meeting Information
2. Olağan Genel Kurulu Tescil ve İlanı
Turkish 672.0 KB
2025-07-07 11:08
Pre-Annual General Meeting Information
2. Olağan Genel Kurulu Tescil ve İlanı
Turkish 14.5 KB

Automate Your Workflow. Get a real-time feed of all RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for RTA LABORATUVARLARI BİYOLOJİK ÜRÜNLER İLAÇ VE MAKİNE SANAYİ TİCARET A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Celon Pharma S.A. Logo
Researches, develops, and markets innovative drugs for oncology and neurology.
Poland
CLN
CEL SCI CORP Logo
Develops immunotherapies for cancer, autoimmune, and infectious diseases.
United States of America
CVM
Celularity Inc Logo
Develops off-the-shelf cell therapies from placentas for cancer and aging-related diseases.
United States of America
CELU
Centessa Pharmaceuticals plc Logo
Develops medicines for sleep-wake disorders, hemophilia, and other unmet medical needs.
United States of America
CNTA
CERO THERAPEUTICS HOLDINGS, INC. Logo
Develops engineered T-cell immunotherapies for cancer using its proprietary CER platform.
United States of America
CERO
CervoMed Inc. Logo
Developing CNS therapeutics for neurodegenerative diseases like dementia with Lewy bodies.
United States of America
CRVO
Cessatech A/S Logo
Develops a non-invasive nasal spray for acute pain relief in children during medical procedures.
Denmark
CESSA
CG Invites Co., Ltd. Logo
Biopharma advancing precision medicine with drugs, mRNA vaccines, and digital therapeutics.
South Korea
083790
CG Oncology, Inc. Logo
Developing bladder-sparing oncolytic immunotherapies for patients with bladder cancer.
United States of America
CGON
CHA Vaccine Research Institute Logo
Develops vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.
South Korea
261780

Talk to a Data Expert

Have a question? We'll get back to you promptly.